Table 2.
Implant and patient survival
| Survival | 5 years | 10 years | 15 years | 20 years | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| % | 95% CI | % | 95% CI | % | 95% CI | % | 95% CI | |||||
| Lower | Upper | Lower | Upper | Lower | Upper | Lower | Upper | |||||
| Implant survival | ||||||||||||
| Low grade (n = 9) | 100.0 | 75.0% | 42.6% | 100.0% | 37.5% | 8.4% | 100.0% | 37.5% | 8.4% | 100.0% | ||
| Stage IIA/IIB (n = 43) | 93.0% | 84.0% | 100.0% | 88.1% | 76.1% | 100.0% | 71.2% | 51.1% | 99.1% | 38.1% | 17.0% | 85.4% |
| Custom (n = 23) | 89.5% | 76.7% | 100.0% | 83.9% | 68.7% | 100.0% | 62.9% | 42.9% | 92.2% | 35.4% | 16.0% | 78.1% |
| Modular (n = 29) | 87.5% | 67.3% | 100.0% | 87.5% | 67.3% | 100.0% | 87.5% | 67.3% | 100.0% | NA | ||
| Overall (n = 52) | 93.8% | 85.9% | 100.0% | 86.4% | 74.7% | 99.9% | 65.8% | 46.7% | 92.7% | 37.0% | 17.1% | 80.2% |
| Patient survival by diagnosis | ||||||||||||
| Low grade (n = 9) | 100.0 | 100.0 | 100.0 | 100.0 | ||||||||
| Stage IIA/IIB (n = 43) | 81.2% | 69.6% | 94.8% | 69.9% | 55.4% | 88.1% | 69.9% | 55.4% | 88.1% | 69.9% | 55.4% | 88.1% |
95% CI = 95% confidence interval; NA = not applicable.